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Breastfeeding in Patients With Heart Failure Lack of Evidence and Consensus
We read with interest the paper by Koczo et al. (1) .
Breastfeeding in patients with peripartum cardiomyopathy (PPCM) remains highly controversial. Because positive effects for the health of both mothers and infants have been reported, exclusive breastfeeding is recommended in healthy women up to 6 months. In contrast, convincing data are scarce regarding infant safety and breastfeeding women who take medications, and evidence to support breastfeeding by critically ill women is lacking (2) . Potential long-term sequelae induced by drugs may be underestimated for the mother and the infant. Third, in their original IPAC report (4), the authors described significant numbers of heart transplantations, ventricular assist device implantations, and deaths. Moreover, there was a substantial difference in outcome depending on the LVEF at initial diagnosis (<30% vs. >30%). Event rates (ventricular assist device implantation or death) in the first year postpartum were significantly higher in patients with LVEF <30% at baseline. These important outcome data are not included in the current analysis (1).
In summary, it is not possible to make conclusions regarding outcome and prognosis of PPCM patients with moderate to severe heart failure based on this analysis (1) . Given the concerns, we advocate against broadly recommending breastfeeding in patients with PPCM, particularly in women with severe heart failure. In line with this advice, the European Society of Cardiology advises against breastfeeding in women with severe heart failure (Class IIb recommendation) (5) . If a shared decision is made to continue breastfeeding (e.g., in patients with mild to moderate heart failure), cautious use of heart failure drugs is recommended (6). IPAC tended to have a higher baseline ejection fraction.
Our study supports that in women with compensated heart failure, breastfeeding does not limit myocardial recovery. Physicians should not deter women who feel well enough to breastfeed based on any theoretical concerns about the safety of heart failure medications or subsequent impact on myocardial recovery. We agree that more studies are needed to elicit the potential impacts of breastfeeding on outcomes in PPCM patients with more symptomatic heart failure and worse baseline cardiac function.
